Completed
Antiviral Activity and Safety of 3 Different Doses of Mifepristone in Hepatitis C Infected Patients
NCT00255177
- Conditions
- Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
- Locations
-
- University of Connecticut Farmington, Connecticut, United States
- Orlando Clinical Research Center Orlando, Florida, United States
- Saint Louis University St Louis, Missouri, United States
- University of Pennsylvania Philadelphia, Pennsylvania, United States